{"cve":"CVE-2015-3965","nvd":{"published":"2019-03-23T20:29:00.193","modified":"2026-06-17T00:26:33.287","status":"Modified","description":"Hospira Symbiq Infusion System 3.13 and earlier allows remote authenticated users to trigger \"unanticipated operations\" by leveraging \"elevated privileges\" for an unspecified call to an incorrectly exposed function.","cvss_v4":null,"cvss_v3":{"version":"3.0","vector":"CVSS:3.0/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H","score":8.8},"cwes":["CWE-264"],"references":["https://ics-cert.us-cert.gov/advisories/ICSA-15-174-01","https://ics-cert.us-cert.gov/advisories/ICSA-15-174-01"],"products":["pfizer:symbiq_infusion_system_firmware"],"source":"nvd","synced_at":"2026-10-19T20:55:22.313337056+00:00"},"epss":{"cve":"CVE-2015-3965","score":0.02882,"percentile":0.8686,"date":"2026-10-31"},"kev":null,"osv":[],"attribution":["This product uses the NVD API but is not endorsed or certified by the NVD.","EPSS scores: FIRST Exploit Prediction Scoring System, https://www.first.org/epss","Known exploited vulnerabilities: CISA Known Exploited Vulnerabilities Catalog, https://www.cisa.gov/known-exploited-vulnerabilities-catalog","Package advisories: OSV (https://osv.dev), from the GitHub Advisory Database, PyPA, Go, RustSec and other ecosystem databases, under CC-BY 4.0 or CC0","CVE records: the CVE Program's CVE List (https://www.cve.org), under its terms of use (https://www.cve.org/Legal/TermsOfUse). CVE is a registered trademark of The MITRE Corporation; this product is not affiliated with the CVE Program."]}